|
|
Bibliometric analysis on the treatment of Hashimoto thyroiditis with traditional Chinese medicine in the past 40 years |
ZHAO Xueru1 CHEN Jidong2 MA Li1 |
1.College of Information Engineering, Hubei University of Chinese Medicine, Hubei Province, Wuhan 430065, China;
2.the First Clinical Medical College, Hubei University of Chinese Medicine, Hubei Province, Wuhan 430065, China |
|
|
Abstract Objective To understand the research status and development trend of Hashimoto thyroiditis treated by traditional Chinese medicine in China, and to provide reference for related scientific research in this field in the future. Methods The literatures related to the treatment of Hashimoto thyroiditis with traditional Chinese medicine in the past 40 years was selected, and the retrieval time was limited from January 1979 to December 2019. CiteSpace software was used for literature visualization analysis. Results A total of 403 literatures were included in the analysis. Four core clusters were formed by the co-author network. Two core organization teams, namely Shanghai and Nanjing, were formed by institutional clustering knowledge graph. The co-occurrence map was formed by 12 keywords with centrality above 0.1, such as “high iodine area”, “integrated treatment of traditional Chinese and Western medicine” and “preventive treatment of disease”. Conclusion The core author team in this field has gradually formed, and the research organization team has typical regional characteristics. The integrated treatment of traditional Chinese and Western medicine has become the mainstream treatment scheme. The prevention of disease and the inheritance of the experience of famous and veteran Chinese medicine will be the key research directions in the treatment of Hashimoto thyroiditis with traditional Chinese medicine in the future.
|
|
|
|
|
[1] Feldt-Rasmussen U. Hashimoto’s thyroiditis as a risk factor for thyroid cancer [J]. Curr Opin Endocrinol Diabetes Obes,2020,27(5):364-371.
[2] Mazokopakis EE. Iodized table salt consumption among patients with Hashimoto’s thyroiditis [J]. Hormones (Athens),2021,20(1):217.
[3] 方露,朱武飞,廖翔宇,等.桥本氏甲状腺炎患者年龄、性别分布及自身免疫抗体水平分析[J].微循环学杂志,2020, 30(1):69-72.
[4] 钟欣婵,郑敏.中医药治疗桥本甲状腺炎的研究进展[J].医学综述,2016,22(2):325-328.
[5] Ahmed R,Al-Shaikh S,Akhtar M. Hashimoto Thyroiditis:a century later [J]. Adv Anat Pathol,2012,19(3):181-186.
[6] 吴梅,李更青,张继全,等.桥本甲状腺炎的中医药治疗研究进展[J].安徽医药,2018,22(10):1859-1863.
[7] 陈继东,赵勇,裴迅,等.中药方治疗桥本甲状腺炎疗效的Meta分析[J].中华中医药学刊,2016,34(4):833-837.
[8] 周彤,梁栋,罗伟康,等.中医药治疗桥本甲状腺炎临床研究概况[J].山东中医药大学学报,2018,42(6):557-560.
[9] 丁学东.文献计量学基础[M].北京:北京大学出版社,1993.
[10] 陈汉平,胡国胜,何金森,等.针灸治疗自身免疫性甲状腺疾病的作用特点[J].中国针灸,1991,11(6):33-36.
[11] 高卫卫,姚昶.温阳化痰法治疗桥本氏甲状腺炎60例临床观察[J].云南中医药杂志,2010,31(1):18-19.
[12] 张仕衡,杨宇峰,石岩.瘿病之病因病机理论框架研究[J].辽宁中医药大学学报,2020,22(10):120-122.
[13] 王伦香,何晓惠.瘿病的辨证论治浅析[J].贵阳中医学院学报,2019,41(6):5-7.
[14] 王福凯,马双双,梁栋,等.桥本氏甲状腺炎病因病机与中医命名思考[J].时珍国医国药,2018,29(12):2998-3000.
[15] 冯静,周志刚,郑寒丹,等.近十年中医药治疗桥本甲状腺炎概况与思考[J].江西中医药,2019,50(5):70-74.
[16] 徐蓉娟,葛芳芳.“病证结合”辨治桥本甲状腺炎[J].上海中医药大学学报,2016,30(1):1-3.
[17] 邵迎新,汪虹,周云.桥本甲状腺炎的病因病机探析[J].中医研究,2020,33(7):4-6.
[18] 刘莹,李昀昊,杨宏杰.桥本甲状腺炎的中医治疗研究进展[J].湖南中医杂志,2017,33(6):183-185.
[19] 付佳温,沈远东,陆灏.桥本氏甲状腺炎的中医研究进展[J].上海中医药大学学报,2016,30(3):102-106.
[20] 庞洁,叶丽娅,伍锐敏.中药加小剂量甲状腺片治疗桥本氏甲状腺炎36例临床观察[J].中医杂志,2001,42(9):543-545.
[21] 陈岳祺,范源,阮凌玉,等.桥本氏甲状腺炎中医体质分布特征与甲状腺激素相关性研究[J].西部中医药,2020, 33(2):66-68.
[22] 李红典,董陈露,冯伟,等.中医治疗桥本甲状腺炎[J].长春中医药大学学报,2019,35(6):1050-1052.
[23] 袁莉莉,栾迪,杨倩,等.甲状腺疾病与认知障碍的研究进展[J].中国神经精神疾病杂志,2020,46(6):368-371.
[24] 吴雪梅.桥本氏甲状腺炎合并甲状腺癌的临床表现及病理分析[J].中国全科医学,2017,20(S1):72-74. |
|
|
|